SAFX XCF Global, Inc.

Q3 2025 10-Q
Filed: Nov 14, 2025Period ending Sep 30, 2025
Health Care
Industrial Organic ChemicalsSEC EDGAR

XCF Global, Inc. (SAFX) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 14, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • Newly added risk: Failure to retain or attract key personnel including CEO Chris Cooper and CFO Simon Oxley could materially impact growth and operations
  • Operational risk: Recruiting and retaining qualified management and technical staff critical to business execution and growth strategy
+1 more insights

Quarterly Financial Summary
XBRL

Revenue

$10M

Net Income

-$13M

Gross Margin

35.0%

Operating Margin

-90.3%

Net Margin

-131.0%

ROE

-240.0%

Total Assets

$409M

Source: XBRL data from XCF Global, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on XCF Global, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.